Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium

Purpose:Our goal was to evaluate the comparative effectiveness of robot-assisted laparoscopic prostatectomy (RALP) and open radical prostatectomy (ORP) in a multicenter study.Materials and Methods:We evaluated men with localized prostate cancer at 11 high-volume academic medical centers in the Unite...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of urology Vol. 207; no. 1; pp. 127 - 136
Main Authors Chang, Peter, Wagner, Andrew A., Regan, Meredith M., Smith, Joseph A., Saigal, Christopher S., Litwin, Mark S., Hu, Jim C., Cooperberg, Matthew R., Carroll, Peter R., Klein, Eric A., Kibel, Adam S., Andriole, Gerald L., Han, Misop, Partin, Alan W., Wood, David P., Crociani, Catrina M., Greenfield, Thomas K., Patil, Dattatraya, Hembroff, Larry A., Davis, Kyle, Stork, Linda, Spratt, Daniel E., Wei, John T., Sanda, Martin G.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Wolters Kluwer 01.01.2022
Subjects
Online AccessGet full text
ISSN0022-5347
1527-3792
1527-3792
DOI10.1097/JU.0000000000002176

Cover

More Information
Summary:Purpose:Our goal was to evaluate the comparative effectiveness of robot-assisted laparoscopic prostatectomy (RALP) and open radical prostatectomy (ORP) in a multicenter study.Materials and Methods:We evaluated men with localized prostate cancer at 11 high-volume academic medical centers in the United States from the PROST-QA (2003-2006) and the PROST-QA/RP2 cohorts (2010-2013) with a pre-specified goal of comparing RALP (549) and ORP (545). We measured longitudinal patient-reported health-related quality of life (HRQOL) at pre-treatment and at 2, 6, 12, and 24 months, and pathological and perioperative outcomes/complications.Results:Demographics, cancer characteristics, and margin status were similar between surgical approaches. ORP subjects were more likely to undergo lymphadenectomy (89% vs 47%; p <0.01) and nerve sparing (94% vs 89%; p <0.01). RALP vs ORP subjects experienced less mean intraoperative blood loss (192 vs 805 mL; p <0.01), shorter mean hospital stay (1.6 vs 2.1 days; p <0.01), and fewer blood transfusions (1% vs 4%; p <0.01), wound infections (2% vs 4%; p=0.02), other infections (1% vs 4%; p <0.01), deep venous thromboses (0.5% vs 2%; p=0.04), and bladder neck contractures requiring dilation (1.6% vs 8.3%; p <0.01). RALP subjects reported less pain (p=0.04), less activity interference (p <0.01) and higher incision satisfaction (p <0.01). Surgical approach (RALP vs ORP) was not a significant predictor of longitudinal HRQOL change in any HRQOL domain.Conclusions:In high-volume academic centers, RALP and ORP patients may expect similar long-term HRQOL outcomes. Overall, RALP patients have less pain, shorter hospital stays, and fewer post-surgical complications such as blood transfusions, infections, deep venous thromboses, and bladder neck contractures.
Bibliography:Correspondence: Prostate Cancer Care Center, Beth Israel Deaconess Medical Center, Department of Surgery, Harvard Medical School, 330 Brookline Ave., Rabb 440, Boston, Massachusetts 02215 (telephone: 617-667-3739; FAX: 617-667-7292; email: pchang@bidmc.harvard.edu).Funding: PROST-QA and PROST-QA/RP2 Consortium funded by National Institutes of Health Grants R01 CA95662, RC1 CA146596, and RC1 EB011001, as well as the Winship Cancer Institute Fund-a-Cure Initiative from the Dunwoody Country Club. Dr. Chang is supported by a Urology Care Foundation Research Scholar Award, the Martin and Diane Trust Career Development Chair in Surgery, and the Movember Foundation.Jim Hu: supported by "The Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust," PCORI CER-2019C1-15682, PCORI CER-2019C2-17372, and NCI RO1 CA241758. Matthew Cooperberg: none. Peter Carroll: none. Eric Klein: none. Adam Kibel consults for Dendreon and Sanofi. Gerald Andriole: none. Misop Han: none. Alan Partin: none. David Wood: none. Catrina Crociani: none. Thomas Greenfield: none. Dattatraya Patil: none. Larry Hembroff: none. Kyle Davis: none. Linda Stork: none. Daniel Spratt: none. John Wei: none. Martin Sanda: none.Attestation: Dr. Chang had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.Trial Registration: NCT01325506: Effectiveness of Open and Robotic Prostatectomy (PROSTQA- RP2).
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0022-5347
1527-3792
1527-3792
DOI:10.1097/JU.0000000000002176